INBS — INTELLIGENT BIO SOLUTIONS INC.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1725430 ·
Last close
$2.50
Market Cap
$7.55M
52W High
$3.49
52W Low
$1.52
ADV30
115,393
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | — | 535,381 | — | -2,862,712 | — | 6,862,204 | — |
| Dec 2025 | 896,774 | 459,739 | -2,608,591 | -2,677,590 | 17,653,042 | 740,371 | 6,763,231 |
| Sep 2025 | 1,111,797 | 518,291 | -2,737,813 | -2,983,006 | 10,038,309 | 1,660,105 | 6,611,380 |
| Jun 2025 | 843,884 | 335,577 | -2,881,554 | -3,090,104 | 8,249,786 | 1,019,909 | 5,435,962 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-10,954,871
Investing CF
$-294,090
Financing CF
$15,273,714
CapEx
$-361,535
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-12.53
As of
2026-08-23
Balance + Analyst (yfinance extras)
Retained Earnings
$-71,056,373
Inventory
$597,469
Receivables
$1,446,957
ST Investments
—
EBIT TTM
$-11,579,447
Pretax Income TTM
$-11,653,861
Interest Exp TTM
$74,414
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$4,215,175
EBITDA
$-11,145,683
Free Cash Flow
$-7,061,263
Enterprise Value
$5,205,788
Total Cash
$3,992,312
Total Debt
$1,819,160
Shares Out
3,018,188
Trailing EPS
$-8.44
Book Value
$1.90
ROE
-307.7%
ROA
-76.2%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Jun 2025 | 3,052,532 | -10,424,545 | -10,568,733 | 8,249,786 | 5,435,962 | — | -9,677,313 |
| Jun 2024 | 3,111,781 | -10,283,174 | -10,156,759 | 13,778,863 | 5,595,672 | — | -9,571,569 |
| Jun 2023 | 1,256,872 | -8,436,563 | -10,631,720 | 10,354,612 | 6,667,614 | — | -7,377,378 |
| Jun 2022 | 0 | -8,336,876 | -8,306,051 | 12,352,173 | 5,806,402 | — | -3,358,034 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$0.35
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CODX | Co-Diagnostics, Inc. | $7.63M | $1.22 | — |
| ICCM | IceCure Medical Ltd. | $7.78M | $2.27 | — |
| NVNO | enVVeno Medical Corp | $7.07M | $10.35 | — |
| NXL | Nexalin Technology, Inc. | $6.95M | $0.32 | — |
| NDRA | ENDRA Life Sciences Inc. | $6.84M | $4.56 | — |
News headlines (Yahoo Finance, 1h cache)
Intelligent Bio Solutions Announces Completion of Method Comparison Study for the Intelligent Fingerprinting Drug Screening System
2026-08-11 12:30 · Yahoo
Intelligent Bio Solutions Achieves Key Milestone Ahead of Planned FDA 510(k) Submission, Advancing Toward Planned U.S. Market Entry
2026-07-23 12:30 · Yahoo
Intelligent Bio Solutions Completes Precision Testing, Strengthening FDA 510(k) Submission Package Ahead of Planned Entry into Multi-Billion-Dollar U.S. Drug Screening Market
2026-07-21 12:30 · Yahoo
Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry
2026-06-16 12:30 · Yahoo
Intelligent Bio Solutions to Participate in Planet MicroCap Las Vegas Conference over June 16-18
2026-06-04 12:30 · Yahoo
Intelligent Bio Solutions Commences Multi-Site Method Comparison Study for FDA 510(k) Submission
2026-06-02 12:30 · Yahoo
Intelligent Bio Solutions Reports Fiscal Third Quarter Revenue Growth of 46% Year-over-Year
2026-05-13 12:30 · Yahoo
Intelligent Bio Solutions Initiates Validation Study for Rapid Drug Screening Cartridge Targeting 70% Faster Results
2026-04-20 13:15 · Yahoo
Intelligent Bio Solutions Advances Upcoming FDA 510(k) Submission, Successfully Completes Penetration Testing with No Major Vulnerabilities Identified
2026-04-17 12:30 · Yahoo
Intelligent Bio Solutions Completes Clinical Cut-off Study, Advances FDA 510(k) Clinical Program Targeting Multi-Billion-Dollar U.S. Drug Screening Market
2026-04-02 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.